Tango Therapeutics, Inc.
TNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819133
In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Tango Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +6 vs. Q4 2023
- Shares held
- 98.4M
- +4.78M (+5.1%) vs. Q4 2023
- Total value
- $781.2M
- −$145.7M (−15.7%) vs. Q4 2023
- New holders
- 22
- 36 more added
- Sold out
- 16
- 40 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 247 | $6.60B |
| Q1 2026 | 194 | $3.78B |
| Q4 2025 | 170 | $1.53B |
| Q3 2025 | 141 | $1.18B |
| Q2 2025 | 115 | $651.7M |
| Q1 2025 | 122 | $147.0M |
| Q4 2024 | 138 | $329.2M |
| Q3 2024 | 121 | $781.2M |
| Q2 2024 | 120 | $846.0M |
| Q1 2024 | 126 | $781.2M |
| Q4 2023 | 121 | $927.1M |
| Q3 2023 | 100 | $999.9M |
| Q2 2023 | 89 | $226.8M |
| Q1 2023 | 92 | $275.9M |
| Q4 2022 | 82 | $498.4M |
| Q3 2022 | 87 | $246.8M |
| Q2 2022 | 77 | $319.1M |
| Q1 2022 | 72 | $528.2M |
| Q4 2021 | 58 | $741.0M |
| Q3 2021 | 46 | $844.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Tango Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charles Schwab Investment Management Inc | 379,477 | $3.01M | 0.00% | +10,411+2.8% | Added |
| Northern Trust Corp | 401,129 | $3.18M | 0.00% | −11,275−2.7% | Reduced |
| Citadel Advisors LLC | 466,118 | $3.70M | 0.00% | +264,303+131.0% | Added |
| Ensign Peak Advisors, Inc | 506,382 | $4.02M | 0.01% | +11,169+2.3% | Added |
| Goldman Sachs Group Inc | 613,702 | $4.87M | 0.00% | +164,487+36.6% | Added |
| Samsara BioCapital, LLC | 630,000 | $5.00M | 0.77% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 708,385 | $5.62M | 0.06% | 00.0% | Unchanged |
| Bessemer Group Inc | 708,384 | $5.63M | 0.01% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 750,000 | $5.96M | 0.07% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,133,535 | $9.00M | 0.00% | +36,433+3.3% | Added |
| Casdin Capital, LLC | 1,188,349 | $9.44M | 0.70% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 1,350,145 | $10.7M | 0.94% | +503,000+59.4% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,540,000 | $12.2M | 0.21% | 00.0% | Unchanged |
| Artal Group S.A. | 2,194,841 | $17.4M | 0.45% | +2,194,841 | New |
| Adage Capital Partners GP, L.L.C. | 2,294,206 | $18.2M | 0.03% | −1,105,794−32.5% | Reduced |
| State Street Corp | 2,866,098 | $22.8M | 0.00% | +1,887,160+192.8% | Added |
| Bain Capital Life Sciences Investors, LLC | 2,892,663 | $23.0M | 1.85% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,080,885 | $24.5M | 0.00% | +101,673+3.4% | Added |
| BlackRock Inc. | 3,861,362 | $30.7M | 0.00% | −87,914−2.2% | Reduced |
| T. Rowe Price Investment Management, Inc. | 4,321,551 | $34.3M | 0.02% | +4,034,857+1,407.4% | Added |
| Southpoint Capital Advisors LP | 5,276,699 | $41.9M | 0.83% | 00.0% | Unchanged |
| Nextech Invest AG | 5,533,980 | $43.9M | 6.97% | 00.0% | Unchanged |
| Boxer Capital, LLC | 8,198,642 | $65.1M | 3.22% | 00.0% | Unchanged |
| FMR LLC | 9,491,655 | $75.4M | 0.01% | −295,695−3.0% | Reduced |
| EcoR1 Capital, LLC | 13,330,736 | $105.8M | 2.69% | 00.0% | Unchanged |
| TRV GP IV, LLC | 19,201,475 | $152.5M | 73.88% | −162,500−0.8% | Reduced |
| RTW Investments, LP | 0 | $0 | 0.00% | −1,966,752−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −1,111,870−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −101,332−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −65,679−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −56,400−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −34,353−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −23,980−100.0% | Sold out |
| Old Well Partners, LLC | 0 | $0 | 0.00% | −18,400−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −15,413−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −13,750−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −12,780−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −10,711−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| AJOVista, LLC | 0 | $0 | 0.00% | −6,133−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −170−100.0% | Sold out |
| Sawtooth Solutions, LLC | – | – | – | – | Not filed |